Release

Launch of "Rapidchip® D-dimer" A Quantitative Assay Kit for Fibrin Degredation Products

Sekisui Medical Co., Ltd.

"Rapidchip® D-dimer", a product for the rapid measurement of D-dimer concentration in the diagnosis of thrombotic disease, will be released on the 9th of December by Sekisui Medical (part of the Sekisui Chemical Group; President: Mutsumi Fukuda; Head Office: Tokyo, Chuo Ward).

"Rapidchip® D-dimer", designed exclusively for use on the "Rapidpia®" analyzer, can be used for the diagnosis of Deep Vein Thrombosis (DVT), Pulmonary Thromboembolism (PTE) and the like through the quantitative detection of the useful diagnostic marker D-dimer in either whole blood or plasma, without the need for pre-treatment steps such as dilution. Furthermore, as the system runs on single-use cartridges based on the principal of immunochromotrography, it can be used economically and without loss of reagent, for outpatients or even in emergency situations, with an analysis time of only 10 minutes.

Sekisui Medical has also been distributing "Rapidchip® BNP" since 2009, which makes use of the same analyzer, and with the introduction of "Rapidchip® D-dimer" hopes to create an even more significant contribution to patient care.


Reference Information

1.Clinical Significance of D-dimer
D-dimer (D-D dimer) is one of the products of the degradation of stable fibrin by plasmin, stable fibrin itself being produced by the crosslinking of fibrin polymers through the action of activated factor XIII in the coagulation/fibrinolysis system. In the blood, D-dimer (DD) exists as one of a number of complexes including YY/DXD, YD/DY, DD/E.
An increase in the level of D-dimer in the blood can indicate ongoing thrombus production and thrombolysis. It is known as an effective marker in the diagnosis of malignant tumors, obstetric conditions, vascular lesions and diseases such as Disseminated Intravascular Coagulation (DIC), Deep Vein Thrombosis (DVT) and Pulmonary Thromboembolism (PTE).
2. Product Overview
Product Name:
Rapidchip® D-dimer
Intended Use:
Measurement of D-dimer concentration in whole blood or plasma
Assay Principle:
Immunochromatographic method using anti-human D-dimer mouse monoclonal antibody.
Assay Range:
0.2 - 15 μg/mL
(Citrated whole blood only. Can be diluted 2x using saline to allow for analysis up to 30 μg/mL)
Sample Type:
Whole Blood, Plama (Citric Acid, Heparin)
Product Name Package Contents Recommended Retail Price(without tax)
Rapidchip® D-dimer 20 Tests (Includes 1 CAL card) ¥25,000
Sold Separately*
Product Name Package Contents Recommended Retail Price(without tax)
D-dimer Control 2 conc. x 0.5 mL (1 bottle each) ¥4,000
  • *This product is not intended for in-vitro diagnostic use.
3.Properties
  1. (1)Can use either whole blood or plasma without the need to pre-treat such as dilution.
  2. (2)An assay time of only 10 minute allows for fast results.
  3. (3)A single-use, cartridge type test means no loss of reagent, making it economical.
4.Product Pictures
Left:
Rapidchip® D-dimer
Right:
Rapidpia®
Generic Name:
Analyser, protein
Medical device requiring specialist maintenance and management

Rapidchip®, Rapidpia® are trademarks owned by Sekisui Medical Co., Ltd. Japan and are registered in Japan and/or other countries.

Press Contact

Sekisui Medical: General Affairs Group, General Affairs & Personnel Resources Department
Fax:+81-3-3278-8774